Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints
COGMED
Evaluation of a Cognitive Remediation Program on Patients With Bipolar Disorders, With Memory Complaints
2 other identifiers
interventional
41
1 country
1
Brief Summary
Bipolar disorder is a major health concern. Intercritical periods are marked with residual symptoms, both thymic and cognitive, which affects quality of life of patients, but also the quality of observance. The implementation of cognitive remediation programs could be interesting. The aim of this study is to evaluate the overall performance on euthymic bipolar patients with memory complaints included in the program named "COGMED", targeting the working memory. The impact of this program on compliance, quality of life, and memory complaints will be evaluated. The investigator will measure whether there is a correlation between working memory and overall performances. Finally, the investigator will try to achieve a profile of bipolar patients in whom the Cogmed program is particularly effective on a plan of overall performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 1, 2016
CompletedFirst Posted
Study publicly available on registry
December 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedDecember 9, 2016
July 1, 2016
3.3 years
August 1, 2016
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evolution of the global functioning between the inclusion and the end of the program
evaluation of variation of global functioning will be realized by the Functioning Assessment Short Test (FAST) scale after COGMED program.
At 4 weeks
Evolution of the global functioning between the inclusion and the end of the program
evaluation of variation of global functioning will be realized by the Functioning Assessment Short Test (FAST) scale after COGMED program
At 6 weeks
Secondary Outcomes (4)
Observance
At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)
Quality of life
At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)
Correlation between working memory and global functioning
At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)
Memory complaints
At the inclusion and 4 to 6 weeks until the end of the program COGMED (11 to 13 weeks after inclusion)
Study Arms (1)
COGMED program
EXPERIMENTALCognitive remediation using COGMED program on bipolar euthymic patients with memory complaints
Interventions
Patient should connect on his computer at home, 5 times a week, for 5 weeks. Every day, the patient has to do 8 exercises for a total duration of 30 to 45 minutes. In total, the patient will have to complete 25 sessions. The difficulty level of the proposed items adjust automatically to the patient's maximum capacity to compel him to provide a cognitive effort. A progression index assesses the progress made by the patient. Every week, the investigator will call the patient for 10 minutes in order to gather the patient's feelings, his difficulties, provide some advice and encourage him. The investigator will have to analyze the results of curves available for each event, as well as the patient's progress index.
Eligibility Criteria
You may qualify if:
- Being diagnosed bipolar according to the Diagnostic and Statistical Manual of Mental Disorders - IV (DSM-IV) criteria
- Memory complaints or overall performance alterations according to the memory scale (MEM III Wechsler memory scale - third edition)
- Not being treated with electroconvulsive therapy for the last year
- Not having drug-dependance or drug-abuse for the last six months
- Having a computer with internet and a cellphone at home
- Having signed informed consent
- Able to understand nature, aims and methodology of the study
You may not qualify if:
- Patient on protective measures (guardianship or trusteeship)
- Deprived of liberty subject (judicial or administrative decision)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montpellier University Hospital
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2016
First Posted
December 9, 2016
Study Start
July 1, 2014
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
December 9, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share